MedTrace Logo

Qatar Diabetes Mobile Application Trial

NCT03998267 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2020-02-17

No results posted yet for this study

Summary

Diabetes mobile technology is an emerging and rapidly expanding field that seeks to combine cutting edge behavioral insights with best practice in diabetes self management education to improve patient empowerment and deliver better patient outcomes.The question that arises is whether or not, diabetes mobile applications are effective in improving glycemic control, clinical outcomes, quality of life and overall patient satisfaction, in diabetic patients in Qatar. To answer this, we plan to enroll 90 diabetic patients into a custom-made diabetes app for Qatar (Droobi) (as intervention group) in comparison with 90 diabetic patients followed in the current standard care, matched in characteristics (as control group). We have the hypothesis that with utilization of the mobile application, patients will have improved glycemic control, improved self management and patient empowerment; together with improved patient-educator/doctor interaction.

Conditions

  • Type2 Diabetes Mellitus

Interventions

DEVICE

Droobi

A new mobile application, specifically built for the diabetes patients in Qatar with the help of local expertise.

OTHER

Standard of care

Standard of care including physicians, dietetics and diabetes educators support

Sponsors & Collaborators

  • Qatar Computing Research Institute (QCRI)

    collaborator UNKNOWN

  • Droobi Health

    collaborator UNKNOWN

  • Hamad Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Noor N Suleiman, MD · Hamad Medical Corporation

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-22
Primary Completion
2020-08-17
Completion
2020-12-31

Countries

  • Qatar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03998267 on ClinicalTrials.gov